Alberto Papi mainly focuses on COPD, Immunology, Asthma, Respiratory disease and Internal medicine. His COPD study integrates concerns from other disciplines, such as Oxidative stress, Intensive care, Pathology, Sputum and Lung. His work on Immunology deals in particular with Rhinovirus, Exacerbation, Inflammation, Cytokine and Chemokine.
His Asthma research incorporates elements of Eosinophilia, Placebo and Anesthesia. His studies deal with areas such as Respiratory tract, Pathophysiology and Vital capacity as well as Respiratory disease. While the research belongs to areas of Internal medicine, Alberto Papi spends his time largely on the problem of Gastroenterology, intersecting his research to questions surrounding Bronchodilator.
His scientific interests lie mostly in Internal medicine, COPD, Asthma, Immunology and Exacerbation. In general Internal medicine, his work in Corticosteroid, Fluticasone propionate and Dupilumab is often linked to In patient linking many areas of study. In his study, which falls under the umbrella issue of COPD, MEDLINE is strongly linked to Pulmonary disease.
His study in Asthma is interdisciplinary in nature, drawing from both Anesthesia, Pediatrics and Intensive care medicine. His Exacerbation research is multidisciplinary, relying on both Beclometasone dipropionate and Metered-dose inhaler. His studies in Rhinovirus integrate themes in fields like Respiratory epithelium and ICAM-1.
His primary scientific interests are in Internal medicine, Asthma, COPD, Exacerbation and Intensive care medicine. His study in the fields of Dupilumab, Adverse effect and Corticosteroid under the domain of Internal medicine overlaps with other disciplines such as In patient. His Asthma research includes elements of Moderate to severe and Lama.
His COPD research includes themes of Pulmonary disease, Clinical trial, Metered-dose inhaler and Immunology. His work is dedicated to discovering how Exacerbation, Inhaler are connected with Fluticasone propionate and other disciplines. Alberto Papi works mostly in the field of Intensive care medicine, limiting it down to topics relating to Disease and, in certain cases, Comorbidity, as a part of the same area of interest.
The scientist’s investigation covers issues in Internal medicine, COPD, Asthma, Intensive care medicine and Exacerbation. Alberto Papi combines subjects such as Omalizumab and Placebo with his study of Internal medicine. His COPD study combines topics from a wide range of disciplines, such as Pulmonary disease, Respiratory infection, Clinical trial and Pneumonia.
His research integrates issues of Gastroenterology, Lower risk, Inhalation and Randomized controlled trial in his study of Asthma. His work carried out in the field of Intensive care medicine brings together such families of science as Disease, Asthma control and MEDLINE. The study incorporates disciplines such as Exhaled nitric oxide, Triple combination, Indacaterol and Risk factor in addition to Exacerbation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
First result from the Alpha Magnetic Spectrometer on the International Space Station: precision measurement of the positron fraction in primary cosmic rays of 0.5-350 GeV.
M Aguilar;G Alberti;B Alpat;A Alvino.
Physical Review Letters (2013)
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
Alberto Papi;Cinzia Maria Bellettato;Fausto Braccioni;Micaela Romagnoli.
American Journal of Respiratory and Critical Care Medicine (2006)
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Eugene R Bleecker;J Mark FitzGerald;Pascal Chanez;Alberto Papi.
The Lancet (2016)
Role of deficient type III interferon-λ production in asthma exacerbations
Marco Contoli;Simon D Message;Vasile Laza-Stanca;Michael R Edwards.
Nature Medicine (2006)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.
Dave Singh;Alvar Agusti;Antonio Anzueto;Peter J. Barnes.
European Respiratory Journal (2019)
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma
B Abraham;JM Anto;E Barreiro;Ehd Bel.
European Respiratory Journal (2003)
Rhinoviruses Infect the Lower Airways
Nikolaos G. Papadopoulos;Philip J. Bates;Philip G. Bardin;Alberto Papi.
The Journal of Infectious Diseases (2000)
Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease
Leonardo M. Fabbri;Micaela Romagnoli;Lorenzo Corbetta;Gianluca Casoni.
American Journal of Respiratory and Critical Care Medicine (2003)
Electron and Positron Fluxes in Primary Cosmic Rays Measured with the Alpha Magnetic Spectrometer on the International Space Station
M. Aguilar;D. Aisa;A. Alvino;G. Ambrosi.
Physical Review Letters (2014)
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics
Paola Panina-Bordignon;Alberto Papi;Margherita Mariani;Pietro Di Lucia.
Journal of Clinical Investigation (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: